| Title |
|
OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy. |
|
|
| Publication Date |
|
| Author(s) |
|
| Subject |
|
| Type of document |
|
| OrcId |
|
| DOI |
|
| Abstract |
|
The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emerging fortuitously from clinical observation is now supported by class one evidence and over two decades of real-world clinical data. There is still limited ability to predict a clinically meaningful response to OnaB-A for individual patients, however. This review summarises briefly the proposed mechanism of OnaB-A in chronic migraine, the literature of predictors of clinical response, and recent developments in the field. |
|
|
| Link |
|
| Citation |
|
Journal of Clinical Medicine 2021; 10(13): 2898 |
|
|
| Jornal Title |
|
Journal of Clinical Medicine |
|
|
| ISSN |
|
